Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of oral fecal microbiota transplantation using frozen stool capsules for maintenance treatment of pediatric-onset ulcerative colitis
2020-000311-71Phase 2Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2021
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of fecal microbiome transplant in autoimmune colitis, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Increase in microbiota richness at 6 months. Started Sep 2021; status: active.
02
Drugs
fecal microbiome transplant
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2020-000311-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000311-71.